EN
HI
Summary
As of 9 Sep, 2026, Natco Pharma stock price is ₹826.3. During the trading session, the stock has moved between an intraday low of ₹815.20 and an intraday high of ₹838.90. Over the last 52 weeks, Natco Pharma has traded between ₹789.00 and ₹1226.80.
The stock has recorded a trading volume of 5,37,495 shares,. Its Average Traded Price (ATP) is ₹825.74, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 27 @ ₹826.30.
Natco Pharma has an upper circuit limit of ₹990.90 and a lower circuit limit of ₹660.60. The total value traded stands at ₹44.38 CR, and the delivery percentage for the day is 61.01%.
The stock is currently traded with a market lot size of 1. Natco Pharma also offers a dividend yield of 0.61%.
Natco Pharma Share Price Chart
Natco Pharma Share Key Metrics
Volume
5.37 L
Market Cap
14799.85 CR
LTQ@LTP
27@826.30
ATP
825.74
Var Margin
18.65 %
Circuit Range
660.6-990.9
Delivery %
61.01 %
Value
44.38 CR
ASM/GSM
No
Market Lot
1
Natco Pharma Fundamentals
P/E Ratio
12.93
P/B Ratio
1.58
Div. Yield
0.61
Sector P/E
41.95
Sector P/B
3.63
Sec. Div. Yield
0.5
Natco Pharma Resistance and Support
Pivot 832
Resistance
First Resistance
840.6
Second Resistance
855.45
Third Resistance
864.05
Support
First Support
817.15
Second Support
808.55
Third Support
793.7
Natco Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Sep 09 2026 | 827.9 | 826.3 | 0.07% | 838.9 | 815.2 |
| Tue Sep 08 2026 | 838.29 | 825.75 | -1.50% | 846.84 | 823.4 |
| Mon Sep 07 2026 | 829 | 838.29 | 1.16% | 841.5 | 828 |
Natco Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results & Interim Dividend |
| 2026-05-29 | Audited Results |
| 2026-03-24 | Scheme of Arrangement |
| 2026-02-12 | Quarterly Results & Interim Dividend |
| 2025-11-14 | Quarterly Results & Interim Dividend |
| 2025-08-12 | Quarterly Results & Interim Dividend |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results & Interim Dividend |
| 2024-11-12 | Quarterly Results & Interim Dividend |
| 2024-08-12 | Quarterly Results & Interim Dividend |
Natco Pharma News
Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Issue of Securities
Natco Pharma proposes a Rights Issue of Equity Shares to raise up to Rs.1,300 crore. The proceeds will be used for pre-payment of outstanding borrowings, funding R&D initiatives, and supporting inorganic growth plans.
Sep 09 2026 17:51:49
Natco Pharma Ltd - 524816 - Board Meeting Outcome for Outcome Of Board Meeting
Natco Pharma's board approved a rights issue for up to ₹1,300 crore. A fund-raising committee has been constituted, and the rights issue will lead to consequential changes in the demerger scheme with Natco Crop Health Sciences Limited.
Sep 09 2026 11:47:40
Read More
Natco Pharma Management
| Name | Position |
|---|---|
| Chekuri Venkat Ramesh | Company Secretary & Compliance Officer |
| V C Nannapaneni | Chairman & Managing Director |
Natco Pharma Similar Stocks
Alembic Pharmaceuticals Ltd.
817.40
8.90 (1.10%)
Vijaya Diagnostic Centre Ltd.
1498.90
-4.10 (0.27%)
Marksans Pharma Ltd.
330.15
-5.75 (1.71%)
Jubilant Pharmova Ltd.
1019.00
21.25 (2.13%)
Concord Biotech Ltd.
1464.50
-6.00 (0.41%)
Sudeep Pharma Ltd.
1277.30
-66.90 (4.98%)
Rainbow Children's Medicare Ltd.
1451.10
1.20 (0.08%)
Molbio Diagnostics Ltd.
1257.90
140.40 (12.56%)
CORONA Remedies Ltd.
2197.20
104.00 (4.97%)
Natco Pharma FAQs
The Buying Price of Natco Pharma share is 826.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Natco Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Natco Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Natco Pharma shares is 12.93. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Natco Pharma shares is 1.58. Useful to assess the stock's value relative to its book value.
To assess Natco Pharma’s valuation compare Sector P/E, P/B which are 41.95 & 3.63 with sector averages, along with growth rates and financial metrics.
The Market Cap of Natco Pharma is 14799.85 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Natco Pharma share price is 1226.80 & 789.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Natco Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in NATCOPHARM
Or Download Choice FinX App
Invest in NATCOPHARM
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade